Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634803 · ClinicalTrials.gov registry record · Phase 1
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT00634803: Completed Phase 1 study, sponsored by Yale University.
NCT00634803 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 90 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00634803, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.
Primary Outcome
Pain intensity comprises the average of 4 items related to current pain and past-week average pain, pain at its worst, and pain at its least. Pain intensity is scored on 0-10 scale (average score ranges from 0-10), where higher scores indicate higher pain intensity.Originally labeled as Pain Reduction at 16 weeks- 3 months was the correct timeframe.
Interventions
- DRUG Buprenorphine
- BEHAVIORAL CBT
- OTHER Physician Management
- OTHER Educational Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
What the finished NCT00634803 record still lists
NCT00634803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 4 interventions - of which Buprenorphine is the first listed.
NCT00634803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00634803 about?
NCT00634803 is a clinical study titled "Clinical Trial of Integrated Treatment for Pain and Opioid Dependence". This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.
What is the current status of trial NCT00634803?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2009-09. Estimated completion is 2015-08.
What interventions are being tested in trial NCT00634803?
The interventions under investigation include: Buprenorphine (DRUG), CBT (BEHAVIORAL), Physician Management (OTHER), Educational Counseling (OTHER).
Who is sponsoring clinical trial NCT00634803?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00634803's enrollment target sits among peer trials
90 628th of 2000 higher than 1,352 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia